Finanzwire Finanzwire
Basculer en Français
10336 Companies
214530 Keywords
144358 Articles
113633 Press releases
Headlines Articles Press releases ActiTrexx GmbH Remove
  1. Home
  2. Companies
  3. ActiTrexx GmbH
Finanzwire
Basculer en Français
Headlines Articles Press releases

News

  • BRIEF

    published on 10/20/2025 at 10:05, 6 months 12 days ago

    ActiTrexx Completes Final Patient Treatment in GvHD Therapy Study

    Clinical Study Graft-versus-Host Disease Actileucel Immune Therapy Regulatory T Cells
  • PRESS RELEASE

    published on 10/20/2025 at 10:00, 6 months 12 days ago

    ActiTrexx completes treatment of last patient with novel regulatory T cell therapy against Graft-versus-Host Disease

    ActiTrexx completes treatment of last patient with novel regulatory T cell therapy against Graft-versus-Host Disease. Phase Ib/II study evaluates Actileucel for GvHD prevention
    ActiTrexx Graft-versus-Host Disease Regulatory T Cell Therapy Actileucel Phase Ib/II Study
    Logo of ActiTrexx GmbH
  • BRIEF

    published on 03/19/2024 at 10:05, 2 years 1 month ago

    ActiTrexx Initiates Treatment in Graft-versus-Host Disease Study with Novel T Cell Therapy

    Clinical Study ActiTrexx Graft-versus-Host Disease Regulatory T Cell Therapy Actileucel
  • PRESS RELEASE

    published on 03/19/2024 at 10:00, 2 years 1 month ago

    ActiTrexx treats first patient with novel regulatory T cell therapy against Graft-versus-Host Disease

    ActiTrexx GmbH treats first patient with novel regulatory T cell therapy for Graft-versus-Host Disease. Phase Ib/II study evaluates safety and feasibility of Actileucel treatment
    Graft-versus-Host Disease Regulatory T Cell Therapy Actileucel ActiTrexx GmbH Phase Ib/II Study
    Logo of ActiTrexx GmbH
Accesswire
  • Published on 05/01/2026 at 18:00, 3 hours 42 minutes ago

    Star Copper to Present at the Emerging Growth Conference on May 7, 2026

  • Published on 05/01/2026 at 15:35, 6 hours 7 minutes ago

    LNG Energy Group Announces Partial Revocation of Cease Trade Order and Proposed Private Placement

  • Published on 05/01/2026 at 14:00, 7 hours 42 minutes ago

    CCL Industries Closing of ALT Technologies Acquisition

  • Published on 05/01/2026 at 14:00, 7 hours 42 minutes ago

    Datavault AI and CyberCatch Announce Signing of Binding Letter of Intent for Datavault AI to Acquire CyberCatch to Accelerate AI-Driven, Quantum-Resistant Cyber Risk Mitigation Solutions

  • Published on 05/01/2026 at 13:01, 8 hours 41 minutes ago

    BeMetals Announces Resumption of Trading on TSX Venture Exchange and Effective Date of Share Consolidation

View all ACCESSWIRE
EQS Group
  • Published on 05/01/2026 at 19:23, 2 hours 18 minutes ago

    Fuller, Smith & Turner PLC: Transaction in own shares

  • Published on 05/01/2026 at 18:40, 3 hours 2 minutes ago

    Holding(s) in Company

  • Published on 05/01/2026 at 17:47, 3 hours 54 minutes ago

    Key Figures 30.04.2026

  • Published on 05/01/2026 at 17:45, 3 hours 56 minutes ago

    Burkhalter Group acquires Progressio Holding GmbH and anplaq ag, Tamins (GR)

  • Published on 05/01/2026 at 17:21, 4 hours 20 minutes ago

    Fuller, Smith & Turner PLC: Total Voting Rights and Treasury Shares

View all EQS
Les Echos
  • Published on 04/30/2026 at 20:00, 1 day 1 hour ago

    AMA Corp PLC : FY 2025 Earnings & Q1 2026 Revenue

  • Published on 04/30/2026 at 19:16, 1 day 2 hours ago

    AXA announces the results of its Shareholders' Meeting

  • Published on 04/30/2026 at 19:00, 1 day 2 hours ago

    Capital increase through exercise of subscription rights

  • Published on 04/30/2026 at 18:10, 1 day 3 hours ago

    Minutes of the Combined General Meeting held on April 30, 2026

  • Published on 04/30/2026 at 18:00, 1 day 3 hours ago

    TF1 Q1 2026 results - Press release

View all LES ECHOS COMFI WIRE

With finanzwire.com, you can follow all the latest financial news in real time from the best sources for companies listed on the Paris, Brussels, Amsterdam, Lisbon, Frankfurt and New York stock exchanges. You'll have access to summary articles written by us and press releases published by the companies themselves.

Finanzwire

87, rue Ordener - 75018 Paris

Contact us

+33 1 42 23 83 61

© 2026 Finanzwire

Contact Authors Cookies policy Terms and conditions Privacy policy